[1] S.R. Flaxman, R.R.A. Bourne, S. Resniko, P. Ackland, T. Braithwaite, M. V Cicinelli,
A. Das, J.B. Jonas, J. Kee, J.H. Kempen, J. Leasher, H. Limburg, K. Naidoo, K.
Pesudovs, A. Silvester, G.A. Stevens, N. Tahhan, T.Y. Wong, Global causes of
blindness and distance vision impairment 1990–2020 : A systematic review and
meta-analysis, lancet glob. Heal. 5 (2020) 1221–1234. doi:https://doi.
org/10.1016/S2214-109X(17)30393-5.
[2] L. Ung, P.J.M. Bispo, S.S. Shanbhag, M.S. Gilmore, J. Chodosh, The persistent
dilemma of microbial keratitis: global burden, diagnosis, and antimicrobial
resistance, Surv. Ophthalmol. 64 (2019) 255–271, https://doi.org/10.1016/j.
survophthal.2018.12.003.
[3] K.J. Ray, L. Prajna, M. Srinivasan, M. Geetha, R. Karpagam, D. Glidden, C.
E. Oldenburg, C.Q. Sun, S.D. McLeod, N.R. Acharya, T.M. Lietman,
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis,
JAMA Ophthalmol. 131 (2013) 310–313, https://doi.org/10.1001/
jamaophthalmol.2013.1718.
[4] N. Venkatesh Prajna, P. Lalitha, R. Rajaraman, T. Krishnan, A. Raghavan,
M. Srinivasan, K.S. O’Brien, M. Zegans, S.D. McLeod, N.R. Acharya, J.D. Keenan, T.
M. Lietman, J. Rose-Nussbaumer, J. Mascarenhas, R. Karpagam, M. Rajkumar, S.
R. Sumithra, C. Sundar, P. Manikandan, N. Shivananda, J.P. Whitcher, S. Lee, B.
L. Shapiro, C.E. Oldenburg, K.C. Hong, M. Fisher, A. Aldave, D. Everett, J. Glover,
K. Ananda Kannan, S. Kymes, I. Schwab, D. Glidden, K. Ray, V. Cevallos, C.M. Kidd,
Changing azole resistance: A secondary analysis of the MUTT I randomized clinical
trial, JAMA Ophthalmol. 134 (2016) 693–696, https://doi.org/10.1001/
jamaophthalmol.2016.0530.
[5] F. Cieplika, D. Dengb, W. Crielaardb, W. Buchallaa, E. Hellwigc, A. Al-Ahmad,
T. Misch, Antimicrobial photodynamic therapy - what we know and what we don’t,
Crit. Rev. Microbiol. 44 (2018) 571–589, https://doi.org/10.1080/
1040841X.2018.1467876.
[6] M. Wainwright, Photodynamic antimicrobial chemotherapy (PACT), J. Antimicrob.
Chemother. 42 (1998) 13–28, https://doi.org/10.1093/jac/42.1.13.
[7] F. Vatansever, W.C.M.A. de Melo, P. Avci, D. Vecchio, M. Sadasivam, A. Gupta,
R. Chandran, M. Karimi, N.A. Parizotto, R. Yin, G.P. Tegos, M.R. Hamblin,
Antimicrobial strategies centered around reactive oxygen species - bactericidal
antibiotics, photodynamic therapy, and beyond, FEMS Microbiol. Rev. 37 (2013)
955–989, https://doi.org/10.1111/1574-6976.12026.
[8] M. Wainwright, T. Maisch, S. Nonell, K. Plaetzer, A. Almeida, G.P. Tegos, M.
R. Hamblin, Photoantimicrobials—are we afraid of the light? Lancet Infect. Dis. 17
(2017) e49–e55, https://doi.org/10.1016/S1473-3099(16)30268-7.
[9] S.A.R. Martins, J.C. Combs, G. Noguera, W. Camacho, P. Wittmann, R. Walther,
M. Cano, J. Dick, A. Behrens, Antimicrobial efficacy of riboflavin/UVA
combination (365 nm) in vitro for bacterial and fungal isolates: a potential new
treatment for infectious keratitis, Investig. Ophthalmol. Vis. Sci. 49 (2008)
3402–3408, https://doi.org/10.1167/iovs.07-1592.
[10] D.G. Said, M.S. Elalfy, Z. Gatzioufas, E.S. El-Zakzouk, M.A. Hassan, M.Y. Saif, A.
A. Zaki, H.S. Dua, F. Hafezi, Collagen cross-linking with photoactivated riboflavin
(PACK-CXL) for the treatment of advanced infectious keratitis with corneal
melting, Ophthalmology. 121 (2014) 1377–1382, https://doi.org/10.1016/j.
ophtha.2014.01.011.
[11] D. Tabibian, C. Mazzotta, F. Hafezi, PACK-CXL: corneal cross-linking in infectious
keratitis, Eye Vis. 3 (2016) 1–5, https://doi.org/10.1186/s40662-016-0042-x.
[12] X. Qin, X. Sun, J. Lu, PACK-CXL: corneal collagen cross-linking for infectious
keratitis, Zhonghua Shiyan Yanke Zazhi/Chinese J. Exp. Ophthalmol. 36 (2018)
570–575, https://doi.org/10.3760/cma.j.issn.2095-0160.2018.07.018.
[13] M.S. Norn, Vital staining of the cornea and conjunctiva with a mixture of
fluorescein and rose Bengal, Am J. Ophthalmol. 64 (1967) 1078–1080, https://doi.
org/10.1016/0002-9394(67)93058-9.
[14] A. Arboleda, D. Miller, F. Cabot, M. Taneja, M.C. Aguilar, K. Alawa, G. Amescua, S.
H. Yoo, J.M. Parel, Assessment of rose bengal versus riboflavin photodynamic
therapy for inhibition of fungal keratitis isolates, Am J. Ophthalmol. 158 (2014),
https://doi.org/10.1016/j.ajo.2014.04.007.
[15] F. Halili, A. Arboleda, H. Durkee, M. Taneja, D. Miller, K.A. Alawa, M.C. Aguilar,
G. Amescua, H.W. Flynn, J.M. Parel, Rose Bengal- and riboflavin-mediated
photodynamic therapy to inhibit methicillin-resistant Staphylococcus aureus
keratitis isolates, Am J. Ophthalmol. 166 (2016) 194–202, https://doi.org/
10.1016/j.ajo.2016.03.014.
[16] A. Naranjo, A. Arboleda, J.D. Martinez, H. Durkee, M.C. Aguilar, N. Relhan,
N. Nikpoor, A. Galor, S.R. Dubovy, H.W. Flynn, D. Miller, J.M. Parel, G. Amescua,
R. Leblanc, Rose Bengal photodynamic antimicrobial therapy for patients with
progressive infectious keratitis: a pilot clinical study, Am J. Ophthalmol. 214
(2020) 198–200, https://doi.org/10.1016/j.ajo.2020.02.001.
[17] G.B. Kharkwal, S.K. Sharma, Y.Y. Huang, T. Dai, M.R. Hamblin, Photodynamic
therapy for infections: clinical applications, Lasers Surg. Med. 43 (2011) 755–767,
https://doi.org/10.1002/lsm.21080.
[18] C. Spagnul, L.C. Turner, R.W. Boyle, Journal of photochemistry and photobiology
B : biology immobilized photosensitizers for antimicrobial applications,
J. Photochem. Photobiol. B Biol. 150 (2015) 11–30, https://doi.org/10.1016/j.
jphotobiol.2015.04.021.
[19] A. Felgentrager, T. Maisch, D. Dobler, A. Spath, Hydrogen bond acceptors and
additional cationic charges in methylene blue derivatives: photophysics and
antimicrobial efficiency, BioMed Reserch Int. (2013), https://doi.org/10.1155/
2013/482167.
Funding
This work was supported by the Japan Society for the Promotion of
Science (JSPS) Kakenhi Grants-in-Aid for Scientific Research (C) [grant
numbers 15K10894 and 18K09411]; and the Tsuchiya Memorial
Foundation [grant number 2017–2018].
Authorship statement
None.
Declaration of Competing Interest
None.
Acknowledgements
We thank Isao Sakata (Porphyrin Laboratory, Okayama, Japan) for
providing information on TONS504 and Akira Ichikawa (CCS, Kyoto,
K. Shinji et al.
Journal of Photochemistry & Photobiology, B: Biology 221 (2021) 112239
[20] L. Bourr´e, F. Giuntini, I.M. Eggleston, C.A. Mosse, A.J. MacRobert, M. Wilson,
Effective photoinactivation of gram-positive and gram-negative bacterial strains
using an HIV-1 tat peptide-porphyrin conjugate, Photochem. Photobiol. Sci. 9
(2010) 1613–1620, https://doi.org/10.1039/c0pp00146e.
[21] K. Sueoka, T. Chikama, Y.D. Pertiwi, J.A. Ko, Y. Kiuchi, T. Sakaguchi, A. Obana,
Antifungal efficacy of photodynamic therapy with TONS 504 for pathogenic
filamentous fungi, Lasers Med. Sci. 34 (2019) 743–747, https://doi.org/10.1007/
s10103-018-2654-y.
[22] Y.D. Pertiwi, T. Chikama, K. Sueoka, J.A. Ko, Y. Kiuchi, M. Onodera, T. Sakaguchi,
Photodynamic antimicrobial chemotherapy with the photosensitizer TONS504
eradicates Acanthamoeba, Photodiagn. Photodyn. Ther. 28 (2019) 166–171,
https://doi.org/10.1016/j.pdpdt.2019.08.035.
[23] M.A. Latief, T. Chikama, M. Shibasaki, T. Sasaki, J.A. Ko, Y. Kiuchi, T. Sakaguchi,
A. Obana, Antimicrobial action from a novel porphyrin derivative in photodynamic
antimicrobial chemotherapy in vitro, Lasers Med. Sci. 30 (2014) 383–387, https://
doi.org/10.1007/s10103-014-1681-6.
[24] M.A. Latief, T. Chikama, J.A. Ko, Y. Kiuchi, T. Sakaguchi, A. Obana, Inactivation of
acyclovir-sensitive and -resistant strains of herpes simplex virus type 1 in vitro by
photodynamic antimicrobial chemotherapy, Mol. Vis. 21 (2015) 532–537.
[25] K. Sueoka, T. Chikama, M.A. Latief, J.A. Ko, Y. Kiuchi, T. Sakaguchi, A. Obana,
Time-dependent antimicrobial effect of photodynamic therapy with TONS 504 on
Pseudomonas aeruginosa, Lasers Med. Sci. 33 (2018) 1455–1460, https://doi.org/
10.1007/s10103-018-2490-0.
[26] Y.D. Pertiwi, T. Chikama, K. Sueoka, J.A. Ko, Y. Kiuchi, M. Onodera, T. Sakaguchi,
Efficacy of photodynamic anti-microbial chemotherapy for Acanthamoeba keratitis
in vivo, Lasers Surg. Med. (2020), https://doi.org/10.1002/lsm.23355 in press.
[27] M. Wilson, Photolysis of oral bacteria and its potential use in the treatment of
caries and periodontal disease, J. Appl. Bacteriol. 75 (1993) 299–306, https://doi.
org/10.1111/j.1365-2672.1993.tb02780.x.
[28] R. Boltes Cecatto, L. Siqueira de Magalh˜
aes, M. Fernanda Setúbal Destro Rodrigues,
C. Pavani, A. Lino-dos-Santos-Franco, M. Teixeira Gomes, D. F´
atima Teixeira Silva,
Methylene blue mediated antimicrobial photodynamic therapy in clinical human
studies: The state of the art, Photodiagn. Photodyn. Ther. 31 (2020), https://doi.
org/10.1016/j.pdpdt.2020.101828.
[29] S. Okazaki, T. Tomo, M. Mimuro, Direct measurement of singlet oxygen produced
by four chlorin-ringed chlorophyll species in acetone solution, Chem. Phys. Lett.
485 (2010) 202–206, https://doi.org/10.1016/j.cplett.2009.12.055.
[30] T. Nishimura, K. Hara, N. Honda, S. Okazaki, H. Hazama, K. Awazu, Determination
and analysis of singlet oxygen quantum yields of talaporfin sodium,
protoporphyrin IX, and lipidated protoporphyrin IX using near-infrared
luminescence spectroscopy, Lasers Med. Sci. 35 (2020) 1289–1297, https://doi.
org/10.1007/s10103-019-02907-0.
[31] M.N. Usacheva, M.C. Teichert, M.A. Biel, The role of the methylene blue and
toluidine blue monomers and dimers in the photoinactivation of bacteria,
J. Photochem. Photobiol. B Biol. 71 (2003) 87–98, https://doi.org/10.1016/j.
jphotobiol.2003.06.002.
[32] A.F. Uchoa, K.T. De Oliveira, M.S. Baptista, A.J. Bortoluzzi, Y. Iamamoto, O.
A. Serra, Chlorin photosensitizers sterically designed to prevent self-aggregation,
J. Organomet. Chem. 76 (2011) 8824–8832, https://doi.org/10.1021/jo201568n.
[33] F. Reifsteck, S. Wee, B.J. Wllklnsont, Hydrophobicity-hydrop hilicity of
staphylococci, J. Med. Microbiol. 24 (1987) 65–73, https://doi.org/10.1099/
00222615-24-1-65.
[34] E. Vanhaecke, J.P. Remon, M. Moors, F. Raes, D. De Rudder, A. Van Peteghem,
Kinetics of Pseudomonas aeruginosa adhesion to 304 and 316-L stainless steel: role
of cell surface hydrophobicity, Appl. Environ. Microbiol. 56 (1990) 788–795,
https://doi.org/10.1128/aem.56.3.788-795.1990.
[35] R.R. Goswami, S.D. Pohare, J.S. Raut, S. Mohan Karuppayil, Cell surface
hydrophobicity as a virulence factor in Candida albicans, Biosci. Biotechnol. Res.
Asia 14 (2017) 1503–1511, https://doi.org/10.13005/bbra/2598.
[36] M.N. Usacheva, M.C. Teichert, M.A. Biel, The role of the methylene blue and
toluidine blue monomers and dimers in the photoinactivation of bacteria,
J. Photochem. Photobiol. B Biol. 71 (2003) 87–98, https://doi.org/10.1016/j.
jphotobiol.2003.06.002.
[37] J.P.M.L. Rolim, M.A.S. De-Melo, S.F. Guedes, F.B. Albuquerque-Filho, J.R. De
Souza, N.A.P. Nogueira, I.C.J. Zanin, L.K.A. Rodrigues, The antimicrobial activity
of photodynamic therapy against Streptococcus mutans using different
photosensitizers, J. Photochem. Photobiol. B Biol. 106 (2012) 40–46, https://doi.
org/10.1016/j.jphotobiol.2011.10.001.
[38] T.P. Paulino, K.F. Ribeiro, G. Thedei, A.C. Tedesco, P. Ciancaglini, Use of hand held
photopolymerizer to photoinactivate Streptococcus mutans, Arch. Oral Biol. 50
(2005) 353–359, https://doi.org/10.1016/j.archoralbio.2004.09.002.
[39] E.S. Nyman, P.H. Hynninen, Research advances in the use of tetrapyrrolic
photosensitizers for photodynamic therapy, J. Photochem. Photobiol. B Biol. 73
(2004) 1–28, https://doi.org/10.1016/j.jphotobiol.2003.10.002.
[40] S.J. Wagner, A. Skripchenko, D. Robinette, J.W. Foley, L. Cincotta, Factors
affecting virus Photoinactivation by a series of phenothiazine dyes, Photochem.
Photobiol. 67 (1998) 343–349, https://doi.org/10.1111/j.1751-1097.1998.
tb05208.x.
[41] G. Jori, C. Fabris, M. Soncin, S. Ferro, O. Coppellotti, D. Dei, L. Fantetti, G. Chiti,
G. Roncucci, Photodynamic therapy in the treatment of microbial infections: basic
principles and perspective applications, Lasers Surg. Med. 38 (2006) 468–481,
https://doi.org/10.1002/lsm.20361.
[42] P.A. Lambert, Cellular impermeability and uptake of biocides and antibiotics in
gram-positive bacteria and mycobacteria, J. Appl. Microbiol. Symp. Suppl. 92
(2002) 46–54, https://doi.org/10.1046/j.1365-2672.92.5s1.7.x.
[43] R.E.W. Hancock, A. Bell, Antibiotic uptake into gram-negative bacteria, Curr. Top.
Infect. Dis. Clin. Microbiol. 2 (1989) 21–28, https://doi.org/10.1007/978-3-32286064-4_5.
[44] F.F. Sperandio, Y.Y. Huang, M.R. Hamblin, Antimicrobial photodynamic therapy to
kill gram-negative Bacteria, Recent Pat. Antiinfect. Drug Discov. 8 (2013)
108–120, https://doi.org/10.2174/1574891x113089990012.
[45] R.A. Prates, I.T. Kato, M.S. Ribeiro, G.P. Tegos, M.R. Hamblin, Influence of
multidrug efflux systems on methylene blue-mediated photodynamic inactivation
of Candida albicans, J. Antimicrob. Chemother. 66 (2011) 1525–1532, https://doi.
org/10.1093/jac/dkr160.
[46] G.A. Da Collina, F. Freire, T.P. Da C. Santos, N.G. Sobrinho, S. Aquino, R.A. Prates,
D. De F.T. Da Silva, A.C.R. Tempestini Horliana, C. Pavani, Controlling methylene
blue aggregation: a more efficient alternative to treat Candida albicans infections
using photodynamic therapy, Photochem. Photobiol. Sci. 17 (2018) 1355–1364.
https://doi.org/10.1039/C8PP00238J.
...
論文の公開元へ
